Carlos Alban
Equibles does not estimate personal net worth.
Get an email with a short summary when AbbVie Inc. publishes a filing, an earnings call transcript or a press release.
Get ABBV alertsAbout Carlos Alban
The proxy statement of AbbVie Inc. reports total compensation of $14,406,090 for Carlos Alban in fiscal 2019, including a base salary of $1,176,538. Disclosed compensation is on record for 3 fiscal years. AbbVie Inc. is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at AbbVie Inc. includes Robert A. Michael (CEO, Chairman, CFO, COO and Board Member), Richard A. Gonzalez (Chairman), Scott T. Reents (CFO) and 5 others.
Affiliation history
-
AbbVie Inc. (ABBV)
Proxy statement
Current
Company network
Leadership on record at AbbVie Inc.
- Robert A. Michael CEO, Chairman, CFO, COO, Board Member
- Richard A. Gonzalez Chairman
- Scott T. Reents CFO
- Dr. John M. Carethers Board Member
- Jennifer Davis Board Member
- Susan Quaggin Board Member
- Thomas Freyman Board Member
- Thomas J. Falk Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2019 | AbbVie Inc. (ABBV) | Vice Chairman, Chief Commercial Officer | $1,176,538 | $14,406,090 |
| 2018 | AbbVie Inc. (ABBV) | Vice Chairman, Chief Commercial Officer | $1,016,526 | $8,983,079 |
| 2017 | AbbVie Inc. (ABBV) | Vice Chairman, Chief Commercial Officer | $947,469 | $12,334,988 |
Recent activity
No call appearances or filed executive changes recorded yet.